Rare Disease Families Can Weigh In on FDA Drug Framework at October 28 Meeting and Through December 11

FDA will hear from rare disease families at an Oct. 28 hybrid meeting, with comments open until Dec. 11. Here is how to register and comment.

Have A Referral?